These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 280246)

  • 21. Schistosoma mansoni: effects of serotonin and serotonin receptor antagonists on motility and length of primary sporocysts in vitro.
    Boyle JP; Zaide JV; Yoshino TP
    Exp Parasitol; 2000 Apr; 94(4):217-26. PubMed ID: 10831389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural specificity of the inhibition of serotonin accumulation in rat lung slices.
    Mais DE; Bosin TR
    Res Commun Chem Pathol Pharmacol; 1981 Nov; 34(2):241-50. PubMed ID: 7335954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Affinities of fluoxetine, its enantiomers, and other inhibitors of serotonin uptake for subtypes of serotonin receptors.
    Wong DT; Threlkeld PG; Robertson DW
    Neuropsychopharmacology; 1991 Aug; 5(1):43-7. PubMed ID: 1930610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of N,N-dimethyltryptamine with central neuroaminergic receptor blocking agents.
    Quock RM; Lum MH; Small SF
    Proc West Pharmacol Soc; 1979; 22():217-8. PubMed ID: 292978
    [No Abstract]   [Full Text] [Related]  

  • 25. Functional interaction between serotonin-S2 and dopamine-D2 neurotransmission as revealed by selective antagonism of hyper-reactivity to tryptamine and apomorphine.
    Awouters F; Niemegeers CJ; Megens AA; Janssen PA
    J Pharmacol Exp Ther; 1990 Sep; 254(3):945-51. PubMed ID: 1697623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypotensive effects of eugenosedin-A with serotonin, alpha- and beta-adrenoceptor antagonistic activities in spontaneously hypertensive and normotensive rats.
    Shen KP; Chiu CC; Chen SJ; Chen IJ; Wu BN
    Pharmacology; 2004 Jun; 71(2):91-101. PubMed ID: 15118348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blockade of para-methoxyamphetamine induced serotonin release by serotonin uptake inhibitors.
    Tseng LF
    Proc West Pharmacol Soc; 1978; 21():7-9. PubMed ID: 308662
    [No Abstract]   [Full Text] [Related]  

  • 28. Neurotoxicity of hydroxylated tryptamines: structure-activity relationships. 1. Long-term effects on monoamine content and fluorescence morphology of central monoamine neurons.
    Baumgarten HG; Björklund A; Nobin A; Rosengren E; Schlossberger HG
    Acta Physiol Scand Suppl; 1975; 429():5-27. PubMed ID: 1064287
    [No Abstract]   [Full Text] [Related]  

  • 29. Motor response secondary to the release of endogenous serotonin by tryptamine in guinea-pig ileal longitudinal muscle with adherent myenteric plexus.
    Takaki M; Mizutani M; Nakayama S
    Arch Int Pharmacodyn Ther; 1988; 291():132-41. PubMed ID: 3365058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The inhibition of (3H) biogenic amine accumulation into rat brain tissue slices by various tryptamine derivatives.
    Heikkila RE; Cohen G
    Res Commun Chem Pathol Pharmacol; 1974 Mar; 7(3):539-47. PubMed ID: 4824828
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of 5,6-dihydroxytryptamine on nerve terminal serotonin and serotonin uptake in the rat brain.
    Björklund A; Nobin A; Stenevi U
    Brain Res; 1973 Apr; 53(1):117-27. PubMed ID: 4697240
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of 5-hydroxytryptamine on neurogenic vasoconstriction in the isolated, autoperfused hindquarters of the rat.
    Calama E; Ortíz de Urbina AV; Morán A; Martín ML; San Román L
    Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):894-900. PubMed ID: 16173953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conformationally constrained N1-arylsulfonyltryptamine derivatives as 5-HT6 receptor antagonists.
    Cole DC; Lennox WJ; Stock JR; Ellingboe JW; Mazandarani H; Smith DL; Zhang G; Tawa GJ; Schechter LE
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4780-5. PubMed ID: 16125933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 7,N,N-Trimethyltryptamine: a selective inhibitor of synaptosomal serotonin uptake.
    Glennon RA; Martin B; Johnson KM; End D
    Res Commun Chem Pathol Pharmacol; 1978 Jan; 19(1):161-4. PubMed ID: 625585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of the stimulus effects of (+)amphetamine by the 5-HT6 antagonist MS-245.
    Pullagurla M; Bondareva T; Young R; Glennon RA
    Pharmacol Biochem Behav; 2004 Jun; 78(2):263-8. PubMed ID: 15219766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New 1-arylindoles based serotonin 5-HT7 antagonists. Synthesis and binding evaluation studies.
    Sagnes C; Fournet G; Satala G; Bojarski AJ; Joseph B
    Eur J Med Chem; 2014 Mar; 75():159-68. PubMed ID: 24531229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Significance of serotonin in the activity of the taste receptor apparatus of the frog Rana temporaria].
    Esakov AI; Golubtsov KV; Solov'eva NA
    Zh Evol Biokhim Fiziol; 1983; 19(1):62-7. PubMed ID: 6601342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of chiral MS-245 analogs at h5-HT6 receptors.
    Abate C; Kolanos R; Dukat M; Setola V; Roth BL; Glennon RA
    Bioorg Med Chem Lett; 2005 Aug; 15(15):3510-3. PubMed ID: 15990303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. De- and regeneration of brain serotonin neurons following 5,7-dihydroxytryptamine treatment: effects on serum LH, FSH and prolactin levels in male rats.
    Wuttke W; Björklund A; Baumgarten HG; Lachenmayer L; Fenske M; Klemm HP
    Brain Res; 1977 Oct; 134(2):317-31. PubMed ID: 890494
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of serotonin on the internal anal sphincter: in vivo manometric study in rats.
    Goldberg M; Hanani M; Nissan S
    Gut; 1986 Jan; 27(1):49-54. PubMed ID: 3949237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.